Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017:2017:1438027.
doi: 10.1155/2017/1438027. Epub 2017 Feb 7.

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?

Affiliations
Clinical Trial

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?

Guangjie Ji et al. Biomed Res Int. 2017.

Abstract

Purpose. To identify pathological characteristics of prostate cancer according to patient age at diagnosis. Methods. A retrospective review of 2,929 men diagnosed with prostate cancer was performed. Pathological characteristics were compared across age groups: ≤55, 56-75, and >75 years. Results. The study cohort included 133 patients (4.5%), 2,033 patients (69.5%), and 763 patients (26.0%) in the three age groups, respectively. The median pathological Gleason sums in the three age groups were 8, 7, and 8, respectively. The Gleason sum, primary Gleason score, and second primary Gleason score were significantly different among the three age groups (Z = 12.975, p = 0.002; Z = 9.264, p = 0.010; Z = 6.692, p = 0.035, resp.). The percentages of Gleason pattern 5 tumors for the three age groups were 44.4%, 32.3%, and 36.8%, respectively; they were significantly different (χ2 = 11.641, p = 0.003). The percentages of tumors with Gleason score grade groups 3-5 for the three age groups were 66.9%, 60.5%, and 66.3%, respectively; they were significantly different (χ2 = 9.401, p = 0.009). Conclusions. The present study indicated that men aged ≤55 years or >75 years show higher levels of clinically significant prostate cancer compared to patients between the ages of 55 and 75 years. Younger and more elderly male patients are more likely to have a more aggressive disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
The distribution of Gleason score (GS) in different age groups.

Similar articles

Cited by

References

    1. Zhou C. K., Check D. P., Lortet-Tieulent J., et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. International Journal of Cancer. 2016;138(6):1388–1400. doi: 10.1002/ijc.29894. - DOI - PMC - PubMed
    1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer Journal for Clinicians. 2012;62(1):10–29. doi: 10.3322/caac.20138. - DOI - PubMed
    1. Salinas C. A., Tsodikov A., Ishak-Howard M., Cooney K. A. Prostate cancer in young men: an important clinical entity. Nature Reviews Urology. 2014;11(6):317–323. doi: 10.1038/nrurol.2014.91. - DOI - PMC - PubMed
    1. Heidenreich A., Bastian P. J., Bellmunt J., et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. European Urology. 2014;65(1):124–137. doi: 10.1016/j.eururo.2013.09.046. - DOI - PubMed
    1. Mohler J. L., Kantoff P. W., Armstrong A. J., et al. Prostate cancer, version 2.2014. Journal of the National Comprehensive Cancer Network. 2014;12(5):686–718. - PubMed

LinkOut - more resources